Buongiorno from the ESC Congress! Earlier this week we had the opportunity to attend the 2016 European Society of Cardiology (ESC) Congress in Rome. ESC has become the largest cardiology meeting in the world with more than 32,000 physicians and other healthcare care professionals in attendance this year. This is one of the most important… Read More
American Heart Month is a timely reminder that more still needs to be done for people at risk for cardiovascular disease. As a lipid specialist, patients are frequently referred to me by their primary care physician because they are struggling to manage their patients’ elevated levels of low-density lipoprotein cholesterol (LDL-cholesterol), or “bad” cholesterol. Often… Read More
By now you’ve read the headlines about the high cost of the new cholesterol lowering drugs. We’ve been bombarded with commentary, articles and opinion pieces on these drugs and their high prices. The PCSK9 inhibitors – injectable, biologic drugs that dramatically lower LDL-cholesterol – appear to be very efficacious. But these drugs are priced at… Read More
This brief video blog features April Seiler, Esperion’s Director of Project Management. In this video, April describes how she has experienced the evolution of ETC-1002 and Esperion 2.0, and her insight into the future of Esperion.
AHA 2014 Scientific Sessions: IMPROVE-IT Results Reported and What They Mean for the Future of ETC-1002
Last month, the American Heart Association (AHA) held its annual Scientific Sessions in Chicago, IL where presenters and attendees gathered from more than 105 countries to present cutting edge breakthroughs in cardiovascular science and research. Esperion colleagues have attended and participated in Scientific Sessions for many years and always look forward to seeing and hearing… Read More
On July 29th, Esperion held its inaugural investor day in New York City, with a tightly-packed agenda for the half-day event that included presentations from several of the world’s leading experts in their respective fields. It was an exciting and informative day! Dr. James McKenney, President and CEO of National Clinical Research, and Professor Emeritus… Read More